Double Point Ventures
Boston, Massachusetts, United StatesFounded 2023
Double Point Ventures is a venture capital firm founded in 2023 and headquartered in Boston, Massachusetts. The firm invests in healthcare and life sciences companies developing therapeutics, diagnostics, medical devices, and digital health products, partnering with founders from early-stage through growth-stage.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (50% of deals). Average disclosed round size is $58.4M (across 11 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
CM
Campbell Murray, MD, MPP, MBA
Co-Founder & Managing Partner
DY
Daniel Yadegar, MD
Co-Founder & Managing Partner
CU
Chris Uzpen
Chief Legal Counsel & Fund Advisor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lighthouse Pharmaceuticals | Series A | $12M | Jan 2026 |
 Umoja | Series C | $100M | Jan 2025 |
 Umoja Biopharma | Series C | $100M | Jan 2025 |
 GEMMABio | Seed | $34M | Dec 2024 |
 ImmunOs Therapeutics | Unknown | $11M | Sep 2024 |
 ImmunOs | Series C | $11M | Sep 2024 |
 Neko Health | Series D | $41M | Jun 2024 |
 Eko Health | Series C | $41M | Jun 2024 |
 Cerevance | Series C | $51M | Apr 2024 |
| Eko Health | Series D | $41M | Jan 2024 |
 Synchron | Series C | — | Dec 2022 |
| Synchron | Series D | $200M | — |
Top Co-Investors
Cormorant Asset Management3 shared
EDBI3 shared
LG Technology Ventures3 shared
NTTVC3 shared
K2 HealthVentures2 shared
Qiming Venture Partners USA2 shared
Alexandria Venture Investments2 shared
CaaS Capital2 shared
MPM Capital2 shared
Gates Frontier2 shared
NTT2 shared
BioMed Ventures2 shared
Mission BioCapital2 shared
Gimv2 shared
Pfizer Ventures2 shared
Protocol Labs2 shared
ARCH Venture Partners2 shared
Bezos Expeditions2 shared
Khosla Ventures2 shared
Earlybird Venture Capital1 shared
Last updated: 7 October 2026